COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations - 1st Edition - ISBN: 9780128000533, 9780128005699

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations

1st Edition

A Global Perspective

Author: Pierre-Louis Lezotre
Hardcover ISBN: 9780128000533
eBook ISBN: 9780128005699
Imprint: Academic Press
Published Date: 5th December 2013
Page Count: 376
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective provides the current status of the complex and broad phenomenon of cooperation, convergence and harmonization in the pharmaceutical sector (Part I), thoroughly evaluates its added value and its critical parameters and influencing factors (Part II) in order to recommend actions and measures to support the next steps for cooperation, convergence and harmonization (Part III). All of these recommendations in the book support the establishment of a better coordinated global pharmaceutical system which represents the best realistic alternative to fulfill the objective to establish a global coalition of regulators and to respond to an increased demand to further cooperation in the pharmaceutical sector. This proposed framework, which leverages all of the ongoing positive cooperation initiatives and uses as foundations all of the numerous harmonization projects developed over the years, presents advantages for all stakeholders and would definitively have significant added value to the promotion and protection of global public health.

Key Features

  • The status of all major worldwide harmonization and cooperation initiatives (at bilateral, regional, and global levels)
  • The value of cooperation in the pharmaceutical sector and the driving factors behind harmonization
  • The proposition of a structure for the global pharmaceutical system and timely recommendations for enhancing international cooperation, as well as further discussion and policy changes in this area


Regulatory professionals from pharmaceutical companies, academia and regulatory agencies worldwide, as well as students in regulatory affairs programs

Table of Contents



About the Author

Foreword by Professor Stuart Walker


Part I. State of Play and Review of Major Cooperation Initiatives


I-1) Global Initiatives

I-2) Regional Initiatives

I-3) Bilateral Initiatives

I-4) Other Cooperation Initiatives

I-5) Conclusion

Part II. Value and Influencing Factors of the Cooperation, Convergence, and Harmonization in the Pharmaceutical Sector


II-1) Value of the Cooperation, Convergence, and Harmonization in the Pharmaceutical Domain

II-2) Critical Parameters and Influencing Factors for Cooperation, Convergence, and Harmonization

Part III. Recommendations to Support the Next Phase of International Cooperation, Convergence, and Harmonization in the Pharmaceutical Domain


III-1) Overview and Key Principles of the Proposed Global Pharmaceutical System

III-2) Recommendations


Acronyms and Abbreviations

List of Figures, Tables and Plates



Color Plates

List of References


Color Plates


No. of pages:
© Academic Press 2013
5th December 2013
Academic Press
Hardcover ISBN:
eBook ISBN:

About the Author

Pierre-Louis Lezotre

Pierre-Louis Lezotre

Dr. Pierre-Louis Lezotre specializes in global regulatory strategy, and is recognized for his passion and expertise

on international cooperation, convergence, and harmonization of regulations for pharmaceutical

and biotechnology products. He has worked in different cultural environments and lived in

both Europe and the United States.

Dr. Lezotre studied biology (University of Sciences, Saint-Etienne, France)

and drug development (University of Pharmacy, Montpellier, France) from

1992 to 1998. He then received his Master in Regulatory Sciences in 1999 (University

of Pharmacy, Lille, France). He also recently completed his PhD in Law with honors (Doctoral

School of “Law, Politics and Management,” University of Law, Lille, France).

Since 1998, Dr. Lezotre has worked for several international pharmaceutical and biotechnology

companies, with increasing levels of responsibility. He has served as a regional and

then global regulatory leader for small molecule and biologic/biotech programs in various

stages of research and development (from early discovery to life cycle management). He

successfully led many global regulatory teams in supporting global registrations of major

products and numerous development projects in several therapeutic areas, including

dermatology, urology, neurology, and pain. He has been responsible for communications

with worldwide Drug Regulatory Authorities and has also worked with external partners/

companies through co-development agreements and business development programs.

Dr. Lezotre has recently been invited to teach courses on international regulation in the

Regulatory Sciences programs of the University of Southern California (USC).

Affiliations and Expertise

PhD, MS, Director, Global Regulatory Affairs, Allergan, Inc., Irvine, CA, USA


“…thoroughly covers the current state of international cooperative initiatives, underlying principles, why cooperation is important, and productive objectives for the future… This book has been selected for The First Clinical Research Bookshelf Essential reading for clinical research professionals.”--Journal of Clinical Research Best Practices, July 2014

Ratings and Reviews